Natus Medical Inc  

(Public, NASDAQ:BABY)   Watch this stock  
Find more results for BABY
28.26
+0.89 (3.27%)
Aug 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 27.40 - 28.48
52 week 12.99 - 29.55
Open 27.51
Vol / Avg. 0.00/243,406.00
Mkt cap 892.42M
P/E 30.65
Div/yield     -
EPS 0.92
Shares 32.31M
Beta 1.04
Inst. own 86%
Oct 22, 2014
Q3 2014 Natus Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 23, 2014
Q2 2014 Natus Medical Inc Earnings Call - Webcast
Jul 23, 2014
Q2 2014 Natus Medical Incorporated Earnings Release
Jun 6, 2014
Natus Medical Incorporated Annual Shareholder Meeting
Jun 4, 2014
Natus Medical Incorporated at Jefferies Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 8.97% 6.65%
Operating margin 11.94% 9.96%
EBITD margin - 15.50%
Return on average assets 7.31% 5.59%
Return on average equity 9.55% 7.96%
Employees 943 -
CDP Score - -

Address

1501 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
United States - Map
+1-650-8020400 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Natus Medical Incorporated (Natus) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company�s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn�s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus categorizes its products into three categories: Hearing, Neurology and Newborn Care. In July 2012, the Company acquired the Nicolet neurodiagnostic business from CareFusion.

Officers and directors

Robert A. Gunst Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James B. Hawkins President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jonathan A. Kennedy Chief Financial Officer, Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Austin F. Noll III Vice President and General Manager - Neurology Strategic Business Unit
Bio & Compensation  - Reuters
Kenneth M. Traverso Vice President, General Manager - Newborn Care Strategic Business Unit
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ajay A. Bhave Vice President - Global Engineering
Age: 57
Bio & Compensation  - Reuters
D. Christopher Chung M.D. Vice President - Medical Affairs, Quality & Regulatory
Age: 50
Bio & Compensation  - Reuters
Doris E. Engibous Independent Director
Age: 59
Bio & Compensation  - Reuters
Kenneth E. Ludlum Independent Director
Age: 60
Bio & Compensation  - Reuters
William M. Moore Jr. Independent Director
Age: 65
Bio & Compensation  - Reuters